￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Will ramucirumab be included in the national medical insurance in China in 2021?

2025-10-19 11:44:20

Check Details
Effectiveness data of ceritinib in first-line treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Where can I buy the new lung cancer drug entrectinib? How much does a box cost?

2025-10-19 11:44:20

Check Details
Safety and effectiveness of ramucirumab combined with erlotinib in the treatment of EGFR mutated lung cancer

2025-10-19 11:44:20

Check Details
Which cancer types is the new anti-cancer drug entrectinib suitable for? What is the anti-cancer effect?

2025-10-19 11:44:20

Check Details
Lung cancer immunotherapy welcomes new drug-nivolumab

2025-10-19 11:44:20

Check Details
Contraindications and precautions for injecting nivolumab in patients with lung cancer

2025-10-19 11:44:20

Check Details
Ceritinib is effective in treating ALK-positive advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Data on the efficacy of nivolumab in the treatment of previously treated advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Can ROS1-mutated lung cancer that is resistant to crizotinib continue to be treated with entrectinib?

2025-10-19 11:44:20

Check Details
New immune therapy for lung cancer-PD-1 inhibitor nivolumab

2025-10-19 11:44:20

Check Details
Can ceritinib treat lung cancer patients who are resistant to alectinib?

2025-10-19 11:44:20

Check Details
Category
相关知识